TruSight Oncology 500 Training

  • Title

    DATE/LENGTH


  • Sequencing: Illumina Technology

    This course provides a general overview of the Illumina sequencing workflow from extraction of nucleic acids to the completion of a sequencing run.

    Languages: French, Italian, German, SpanishChinese (Simplified), French,

    15 min


  • Preventing Contamination

    Many next-generation sequencing applications use the Polymerase Chain Reaction, or PCR, for DNA amplification. This video presents best practices to minimize the potential for PCR contamination in your experiment.

    10 min


  • TruSight Oncology 500: DNA Analysis Overview

    Recorded Webinar (July 2019) | TruSight Oncology 500 is a next-generation sequencing tumor profiling assay that analyzes 523 genes for cancer-related biomarkers and supports the identification of DNA and RNA variants implicated in various tumor types, including measuring key immunotherapy biomarkers such as tumor mutation burden (TMB) and microsatellite instability (MSI). This webinar focuses on the DNA analysis and is targeted at new users of the TruSight Oncology 500 workflow. We will go over the following topics: overview of the TruSight Oncology 500 DNA analysis workflow, how to assess biomarker (TMB and MSI) results, and options for data analysis and variant interpretation


  • TruSight Oncology 500 and TruSight Oncology 500 High Throughput: Introduction & Overview

    Upcoming Webinar |  TruSight Oncology 500 is a next-generation sequencing tumor profiling assay that analyzes 523 genes for cancer-related biomarkers with FFPE samples. The assay supports the identification of DNA and RNA variants implicated in various tumor types, including measuring key immunotherapy biomarkers such as tumor mutation burden (TMB) and microsatellite instability (MSI). This webinar focuses on introducing TruSight Oncology 500/TruSight Oncology 500 High Throughput library preparation and is targeted at new users of the workflow. We will go over the following topics: How to successfully prepare and sequence TruSight Oncology 500 and TruSight Oncology 500 libraries, comparision of TruSignt Oncology 500 and TruSignt Oncology 500 High Throughput workflows, and how to assess key sequencing metrics.

    Jun 11, 2020 PST


  • TruSight Oncology 500: Version 2 Analysis Overview

    Upcoming Webinar |  TruSight Oncology 500 is a next-generation sequencing tumor profiling assay that analyzes 523 genes for cancer-related biomarkers and supports the identification of DNA and RNA variants implicated in various tumor types, including measuring key immunotherapy biomarkers such as tumor mutation burden (TMB) and microsatellite instability (MSI). This provides an overview of TruSight Oncology 500 analysis and is targeted at new users of the TruSight Oncology 500 workflow. We will go over the following topics: overview of the TruSight Oncology analysis workflow, how to assess biomarker (TMB and MSI) results, and options for data analysis and variant interpretation

    Jun 25, 2020 PST